Ra Pharmaceuticals (RARX) Begins Dosing of RA101495 in PNH Patients
Posted on
April 26, 2017 7:12 AM EDTInitial Data from Global Phase 2 Program Expected Mid-2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ra Pharmaceuticals, Inc. (NASDAQ: RARX) today announced that it has initiated dosing in the […]
Read more About Ra Pharmaceuticals (RARX) Begins Dosing of RA101495 in PNH Patients